Ana amfani da kit ɗin don in vitro qualitative gano kwayoyin ORF1ab/N/S na novel coronavirus 2019-nCoV a cikin samfuran numfashi da suka haɗa da swabs oropharyngeal, swab nasopharyngeal, sputum da yin buga maye akan HV69-70 del lokaci guda.Kamar yadda aka ruwaito a cikin GISAID database, fiye da 95% Omicron bambance-bambancen jeri da aka ruwaito sun haɗa da shafewa a cikin HV69-70, wanda zai iya haifar da gazawar S gene target (SGTF) a cikin gwaje-gwajen PCR.Ana iya amfani da SGTF azaman alamar wakili don nunawa Omicron.
An tsara saiti na farko da bincike mai lakabin FAM don takamaiman gano nau'in ORF lab na 2019-nCoV, VIC mai lakabin bincike don N gene na 2019-nCoV, bincike mai lakabin ROX don S gene HV69-70 del mutation na 2019-nCoV.Halin halittar RNase P na ɗan adam da aka fitar a lokaci guda tare da samfurin gwajin yana ba da iko na ciki don tabbatar da aikin hakar nucleic da amincin reagent.Binciken da aka yi niyya na ɗan adam RNase P yana da alamar CY5.
Tsarin PCR na ainihi: Aehealth Diagenex AL, ABI 7500, ViiATM 7, Quant Studio 7 flex.Roche Lightcycler 480, Agilent Mx3000P/3005P, Rotor-GeneTM6000/0.Bio-Rad CEX96 TouchTM SLAN-96S.SLAN-96P, MA 6000;